- Home
- BLDEW vs ESE Comparison
BLDEW vs ESE Comparison
Compare BLDEW & ESE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDEW
- ESE
- Stock Information
- Founded
- BLDEW 2014
- ESE 1990
- Country
- BLDEW United States
- ESE United States
- Employees
- BLDEW 281
- ESE N/A
- Industry
- BLDEW Transportation Services
- ESE Telecommunications Equipment
- Sector
- BLDEW Consumer Discretionary
- ESE Telecommunications
- Exchange
- BLDEW Nasdaq
- ESE Nasdaq
- Market Cap
- BLDEW N/A
- ESE N/A
- IPO Year
- BLDEW N/A
- ESE N/A
- Fundamental
- Price
- BLDEW $0.19
- ESE $175.65
- Analyst Decision
- BLDEW
- ESE Strong Buy
- Analyst Count
- BLDEW 0
- ESE 2
- Target Price
- BLDEW N/A
- ESE $187.50
- AVG Volume (30 Days)
- BLDEW 51.0K
- ESE 175.5K
- Earning Date
- BLDEW 03-13-2025
- ESE 05-07-2025
- Dividend Yield
- BLDEW N/A
- ESE 0.18%
- EPS Growth
- BLDEW N/A
- ESE 19.62
- EPS
- BLDEW N/A
- ESE 4.56
- Revenue
- BLDEW $241,814,000.00
- ESE $1,071,861,000.00
- Revenue This Year
- BLDEW N/A
- ESE $11.52
- Revenue Next Year
- BLDEW N/A
- ESE $17.21
- P/E Ratio
- BLDEW N/A
- ESE $38.51
- Revenue Growth
- BLDEW 12.04
- ESE 8.40
- 52 Week Low
- BLDEW $0.30
- ESE $101.42
- 52 Week High
- BLDEW $0.36
- ESE $174.93
- Technical
- Relative Strength Index (RSI)
- BLDEW N/A
- ESE 68.77
- Support Level
- BLDEW N/A
- ESE $161.61
- Resistance Level
- BLDEW N/A
- ESE $179.42
- Average True Range (ATR)
- BLDEW 0.00
- ESE 4.70
- MACD
- BLDEW 0.00
- ESE 2.15
- Stochastic Oscillator
- BLDEW 0.00
- ESE 88.41
About BLDEW Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.